This retrospective analysis compares VMAT and IMRT in prostate cancer patients, highlighting organ-at-risk sparing and treatment plan quality indices.
A BSTRACT Aim: This study presents a comprehensive dosimetric comparison of volumetric-modulated arc therapy (VMAT) and Intensity-Modulated Radiation Therapy (IMRT) for localized prostate cancer, focusing on organ-at-risk (OAR) sparing and plan quality indices. Materials and Methods: This retrospective analysis was conducted in our hospital, between 2021 and 2023. Treatment plans for 50 prostate cancer patients were evaluated using computed tomography simulation data acquired with a 16-slice scanner at a 3.0 mm slice thickness. All patients were prescribed a total dose of 60 Gy, delivered in 20 fractions (3 Gy per fraction). Treatment planning was performed using 15 MV photon beams on a Varian CLINAC DHX linear accelerator. Each patient had VMAT and IMRT plans generated using the analytical anisotropic algorithm. Dose-volume histograms, irradiation volumes for OARs and dosimetric indices such as conformity index (CI), homogeneity index (HI), and gradient index (GI) were assessed. Statistical analysis using the paired t -tests was conducted. Results: VMAT demonstrated superior performance across all the parameters. The mean CI was 1.11 (VMAT) versus 1.23 (IMRT), HI was 0.09 versus 0.13, and GI was 3.8 versus 4.3 (all P < 0.05). VMAT significantly reduced V50 Gy and V30 Gy for the bladder and rectum. Statistically significant differences ( P < 0.05) were observed in all comparisons. Conclusion: VMAT significantly outperformed IMRT across all dosimetric indices, highlighting its superior ability to minimize the radiation tissue dose to critical organs while maintaining optimal tumor coverage.
No takes yet. Share an insight, caveat, or question.
Baba et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: